subscribeSubscribe
price-trendAsk Us
U.S. Food and Drug Administration Approves Lampit® (nifurtimox)

U.S. Food and Drug Administration Approves Lampit® (nifurtimox)
BUSINESSWIRE
07 Aug 2020
Share Share
Bayer`s Phase III Clinical Trial Of Nifurtimox In Pediatric Patients

Bayer`s Phase III Clinical Trial Of Nifurtimox In Pediatric Patients
PRNECASWIRE.COM/NEWS-RELEASES/BAYERS-PHASE-III-CLINICAL-TRIAL-OF-NIFURTIMOX-IN-PEDIATRIC-PATIENTS-WITH-CHAGAS-DISEASE-MEETS-PRIMARY-ENDPOINT-300812233
15 Mar 2019
Share Share
Bayer`s PhIII Clinical Trial Of Nifurtimox In Pediatric Patients

Bayer`s PhIII Clinical Trial Of Nifurtimox In Pediatric Patients
BIOSPACE
14 Mar 2019
Share Share